|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn962751169 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160620s2016 nyua ob 001 0 eng |
| 010 |
|
|
|a 2020679601
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d EBLCP
|d N$T
|d OCLCF
|d SNK
|d DKU
|d AUW
|d IGB
|d D6H
|d VTS
|d AGLDB
|d G3B
|d S8J
|d S9I
|d STF
|d M8D
|d OCLCO
|d OCL
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9781634857192
|q (ebook)
|
| 020 |
|
|
|a 1634857194
|
| 020 |
|
|
|z 9781634856973
|q (hardback)
|
| 035 |
|
|
|a (OCoLC)962751169
|
| 050 |
0 |
0 |
|a RC845
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.3/62
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Liver disease :
|b diagnosis, treatment and management /
|c Regina Nelson, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2016]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a Hepatology research and clinical developments
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Preface; Chapter 1; Hepatic Hydatidosis; Abstract; I. History of the Disease; II. Description of the Parasite Echinococcus Granulosus; III. Epidemiology of Hydatid Disease; IV. Life Cycle of the Parasite; V. Description of Hydatid Cyst; VI. Clinical Presentation of Hepatic Hydatidosis: Asymptomatic and Symptomatic; VII. Clinical Signs of Hepatic Hydatid Cyst; IX. Sequalae of Hepatic Hydatid Cyst; IX. Differential Diagnosis; X. Investigation of Hepatic Hydatid Disease; Routine and Diagnostic Investigations; Serological Investigation of the Hepatic Hydatidosis
|
| 505 |
8 |
|
|a XI. Treatment: Different ModalitiesSteps of the Operation; References; Chapter 2; Natural History of Chronic Hepatitis C Infection: Epidemiology, Outcomes, and Therapeutic Options; Abstract; Epidemiology; Virology/Molecular Biology; Natural History; Hepatitis C Screening; Diagnosis; History and Physical Examination; Laboratory Tests; Imaging; Testing for Fibrosis and Cirrhosis; Treatment; Indications and Considerations; Interferon and Ribavirin; Direct Acting Antiviral; Management; References; Chapter 3; Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease (NAFLD) and Psoriasis; Abstract
|
| 505 |
8 |
|
|a 1. Introduction2. Metabolic Syndrome; 2.1. Introduction and Definition of Metabolic Syndrome; 2.2. Epidemiology of Metabolic Syndrome; 2.3. Pathophysiology of Metabolic Syndrome; 3. Non-Alcoholic Fatty Liver Disease (NAFLD); 3.1. Introduction and Definition of NAFLD; 3.2. Epidemiology of NAFLD; 3.3. Pathophysiology of NAFLD; 4. Metabolic Syndrome and NAFLD -- The Link; 5. Psoriasis; 5.1. Introduction of Psoriasis; 5.2. Epidemiology of Psoriasis; 5.3. Pathophysiology of Psoriasis; 6. Metabolic Syndrome, NAFLD and Psoriasis -- The Link
|
| 505 |
8 |
|
|a 7. Treatment of Metabolic Syndrome, NAFLD and Skin Inflammation Co-Morbidity8. Animal Models of NAFLD and Psoriasis; Conclusion; References; Chapter 4; Pathophysiology and Treatment of Liver Cirrhosis; Abstract; Introduction; Pathophysiology of Cirrhosis; Cause of Cirrhosis; Symptom and Laboratory Findings of Cirrhosis; Diagnostic Methods for Liver Cirrhosis; Classification of Liver Function for Patients with Liver Cirrhosis; Prognosis of the Cirrhosis; Hypoalbuminemia in Cirrhosis; Ascites in Cirrhosis; Treatment of Cirrhosis; Administration of Albumin; Branched-Chain Amino Acid (Levact ®)
|
| 505 |
8 |
|
|a Albumin SynthesisDiuretics; References; Chapter 5; Surgical Strategies to Push up Resection Limits in Liver Disease and Liver Failure After Surgery; Abstract; Introduction; References; Section 1. Post-Hepatectomy Liver Failure (PHLF); From Transplantation Experience to Oncological Surgery Environment; Epidemiology; Risk Factors; References; Section 2. Classical Approach: The Concept of Size; TLV and FLRV: How to Calculate?; Manual, Semi-Automated and Automated Methods of CTV; References; Rationale and Historical Perspectives of Strategies to Push Up Liver Resection's Limits
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Liver
|x Diseases
|x Diagnosis.
|
| 650 |
|
0 |
|a Liver
|x Diseases
|x Treatment.
|
| 650 |
|
6 |
|a Foie
|x Maladies
|x Diagnostic.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Liver
|x Diseases
|x Treatment
|2 fast
|
| 650 |
|
7 |
|a Liver
|x Diseases
|x Diagnosis
|2 fast
|
| 650 |
|
7 |
|a Liver
|x Diseases
|2 fast
|
| 700 |
1 |
|
|a Nelson, Regina,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Liver disease.
|d New York : Nova Biomedical, [2016]
|z 9781634856973
|w (DLC) 2016945131
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1419207
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4745957
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1419207
|
| 994 |
|
|
|a 92
|b IZTAP
|
